The application discloses methods of treating mammalian diseases characterized
by abnormal cell mitosis by administering estradiol derivatives including those
comprising colchicine or combretastatin A-4 structural motifs of the general formulae
found below in a dosage sufficient to inhibit cell mitosis. The application discloses
novel compounds used in the methods.